Annex XI Documentation
Annex XI Documentation refers to a set of records that certain AI providers are expected to prepare under an annex of the EU AI Act, describing the AI model and how it is intended to be used. Based on the evidence available, this documentation typically includes items such as a general description of the AI model, its intended tasks, acceptable use policies, and its release date. Note that 'Annex XI' also appears in a separate EU regulation for medical devices, where it means something entirely different, so the term should always be read in context.
In the context of the EU Artificial Intelligence Act, Annex XI specifies technical documentation referenced in the Act's relevant article (as indicated by the source), enumerating the information a provider is expected to maintain. Per the evidence, this includes a general description of the AI model, its intended tasks, acceptable use policies, and release date, among other items not fully enumerated in the evidence provided. Practitioners should distinguish this from the identically labeled 'Annex XI' under the EU Medical Device Regulation (MDR), which addresses conformity assessment based on product conformity verification (batch testing or production quality assurance) and is unrelated to AI model documentation. The evidence does not establish the exact article cross-reference, the complete list of required elements, or applicable effective dates, so those details are out of scope here and should be verified against the current consolidated text of the Act.
Why it matters
For providers of certain AI models subject to the EU AI Act, Annex XI Documentation represents part of the paper trail that regulators and downstream parties may rely on to understand what a model is, what it is intended to do, and how it should and should not be used. In many governance frameworks, documentation of this kind serves as the connective tissue between an organization's internal accountability structures and its external obligations, giving oversight functions a reference point for what the provider claims about the model. Maintaining such records is a governance measure that supports transparency and accountability; it does not by itself eliminate the underlying risks associated with a model's development or deployment.
A recurring source of confusion is that the label 'Annex XI' also appears in a separate EU instrument, the Medical Device Regulation, where it refers to conformity assessment based on product conformity verification (for example, batch testing or a production quality assurance system) and has nothing to do with AI model documentation. Professionals working across both domains can easily misattribute requirements from one regime to the other, which can lead to preparing the wrong records or misreading a compliance obligation. Reading the term strictly in the context of the regulation being cited is essential.
The evidence available establishes only a partial picture of the AI Act's Annex XI contents and does not confirm the exact article cross-reference, the complete list of required elements, or applicable effective dates. Because the EU AI Act's documentation obligations are subject to phased application and interpretation, practitioners should treat the items described here as illustrative rather than exhaustive and verify specifics against the current consolidated text.
Who it's relevant to
Inside Annex XI Documentation
Common questions
Answers to the questions practitioners most commonly ask about Annex XI Documentation.